My bookmarksSign up free
Source

Commission Implementing Regulation (EU) 2023/1091 of 5 June 2023 granting a Union authorisation for the single biocidal product ‘APESIN alcogel’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (Text with EEA relevance)

Commission Implementing Regulation (EU) 2023/1091 of 5 June 2023 granting a Union authorisation for the single biocidal product ‘APESIN alcogel’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (Text with EEA relevance)

Implementing Regulation (EU) 2023/1091 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

A Union authorisation with authorisation number EU-0027672-0000 is granted to Tana-Chemie GmbH for the making available on the market and use of the same single biocidal product ‘APESIN alcogel’ in accordance with the summary of the biocidal product characteristics set out in the Annex. The Union authorisation is valid from 26 June 2023 until 31 July 2032.

Article 2

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

Summary of product characteristics for a biocidal product

ANNEXSupplementary provisions

Open ↗

ANNEX Summary of product characteristics for a biocidal product APESIN alcogel Product type 1 - Human hygiene (Disinfectants) Authorisation number: EU-0027672-0000 R4BP asset number: EU-0027672-0000 1.    ADMINISTRATIVE INFORMATION 1.1.    Trade name(s) of the product Trade name(s) E-HDG 1.2.    Authorisation holder Name and address of the authorisation holder Name tana-Chemie GmbH Address Rheinallee 96, 55120 Mainz Germany Authorisation number EU-0027672-0000 R4BP asset number EU-0027672-0000 Date of the authorisation 26 June 2023 Expiry date of the authorisation 31 July 2032 1.3.    Manufacturer(s) of the product Name of manufacturer tana-Chemie GmbH Address of manufacturer Rheinallee 96, 55120 Mainz Germany Location of manufacturing sites Werner & Mertz GmbH & Co KG, Neualmerstr. 13, 5400 Hallein Austria Werner & Mertz GmbH, Rheinallee 96, 55120 Mainz Germany 1.4.    Manufacturer(s) of the active substance(s) Active substance Propan-1-ol Name of manufacturer OQ Chemicals GmbH (formerly Oxea GmbH) Address of manufacturer Rheinpromenade 4a, 40789 Monheim am Rhein Germany Location of manufacturing sites OQ Chemicals Corperation (formerly Oxea Coperation), 2001 FM 3057 TX, 77414 Bay City United States Active substance Propan-1-ol Name of manufacturer BASF SE Address of manufacturer Carl-Bosch-Str. 38, 67056 Ludwigshafen Germany Location of manufacturing sites BASF SE, Carl-Bosch-Str. 38, 67056 Ludwigshafen Germany Active substance Propan-1-ol Name of manufacturer SASOL Chemie GmbH & Co. KG Address of manufacturer Secunda Chemical Operations, Sasol Place, 50 Katherine Street, 2090 Sandton South Africa Location of manufacturing sites Secunda Chemical Operations, PDP Kruger Street, 2302 Secunda South Africa Active substance Propan-2-ol Name of manufacturer INEOS Solvent Germany GmbH Address of manufacturer Römerstrasse 733, 47443 Moers Germany Location of manufacturing sites INEOS Solvent Germany GmbH, Römerstrasse 733, 47443 Moers Germany INEOS Solvent Germany GmbH, Shamrockstrasse 88, 44623 Herne Germany 2.    PRODUCT COMPOSITION AND FORMULATION 2.1.    Qualitative and quantitative information on the composition of the product Common name IUPAC name Function CAS number EC number Content (%) Propan-1-ol   Active Substance 71-23-8 200-746-9 30,0 Propan-2-ol   Active Substance 67-63-0 200-661-7 45,0 2.2.    Type of formulation AL - Any other liquid 3.    HAZARD AND PRECAUTIONARY STATEMENTS Hazard statements Highly flammable liquid and vapour. Causes serious eye damage. May cause drowsiness or dizziness. Repeated exposure may cause skin dryness or cracking. Precautionary statements Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. - No smoking. Keep container tightly closed. Avoid breathing vapours. Use only outdoors or in a well-ventilated area. IF INHALED: Remove person to fresh air and keep comfortable for breathing. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER/doctor. Store in a well-ventilated place. Keep cool. Store locked up. Dispose of container to an authorised waste collection point. 4.    AUTHORISED USE(S) 4.1.    Use description Table 1. Use # 1 – hygienic handrub, gel Product type PT01 - Human hygiene (Disinfectants) Where relevant, an exact description of the authorised use Not relevant Target organism(s) (including development stage) Scientific name: no data Common name: Bacteria Development stage: no data Scientific name: no data Common name: Mycobacteria Development stage: no data Scientific name: no data Common name: Yeasts Development stage: no data Scientific name: no data Common name: Enveloped viruses Development stage: no data Field(s) of use Indoor — hospitals and other health care institutions, ambulances, surgeries, nursing homes (including home-care of patients) — hospital canteens, large kitchens, pharmaceutical industries, production sites, laboratories: hygienic handrub onto visibly clean and dry hands. — For professional use only. Application method(s) Method: Manual application Detailed description: Rubbing Application rate(s) and frequency Application Rate: Dosage: At least 3 ml (use dispensers: for example set to 1,5 ml per stroke, 2 strokes per 3 ml). Contact time: 30 s Dilution (%): Ready-to-use product Number and timing of application: There is no restriction in the number and timing of applications. No safety intervals need to be considered between the application phases. The product may be used at any time and as often as required. Category(ies) of users Industrial Professional Pack sizes and packaging material 100, 125, 500, 1 000 ml in transparent/white high-density polyethylene (HDPE) bottles with polypropylene (PP) flip top caps; 5 000 ml transparent/white HDPE canister with HDPE screwed cap. 500 and 1 000 ml in transparent HDPE lightweight bottle with integrated PP pump. 4.1.1.    Use-specific instructions for use The products can be applied directly or the products can be used in a dispenser or with a pump. For hygienic handrub use 3 ml of product and keep hands wet for 30 seconds. Do not refill. 4.1.2.    Use-specific risk mitigation measures See general directions for use 4.1.3.    Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment See general directions for use 4.1.4.    Where specific to the use, the instructions for safe disposal of the product and its packaging See general directions for use 4.1.5.    Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage See general directions for use 4.2.    Use description Table 2. Use # 2 – surgical handrub, gel Product type PT01 - Human hygiene (Disinfectants) Where relevant, an exact description of the authorised use Not relevant Target organism(s) (including development stage) Scientific name: no data Common name: Bacteria Development stage: no data Scientific name: no data Common name: Mycobacteria Development stage: no data Scientific name: no data Common name: Yeasts Development stage: no data Scientific name: no data Common name: enveloped viruses Development stage: no data Field(s) of use Indoor Hospitals and other health care institutions: surgical handrub onto visibly clean and dry hands and forearms. For professional use only. Application method(s) Method: Manual application Detailed description: Rubbing Application rate(s) and frequency Application Rate: Dosage: Rub sufficient amount in portions of 3 ml (use dispensers: for example set to 1,5 ml per stroke, 2 strokes per 3 ml). Contact time: 90 s Dilution (%): Ready-to-use product Number and timing of application: There is no restriction in the number and timing of applications. No safety intervals need to be considered between the application phases. The product may be used at any time and as often as required. Category(ies) of users Professional Pack sizes and packaging material 100, 125, 500, 1 000 ml in transparent/white high-density polyethylene (HDPE) bottles with polypropylene (PP) flip top caps; 5 000 ml transparent/white HDPE canister with HDPE screwed cap. 500 and 1 000 ml in transparent HDPE lightweight bottle with integrated PP pump. 4.2.1.    Use-specific instructions for use The products can be applied directly or the products can be used in a dispenser or with a pump. For surgical handrub use as many portions of 3 ml as necessary to keep hands wet for 90 seconds. Do not refill. 4.2.2.    Use-specific risk mitigation measures See general directions for use 4.2.3.    Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment See general directions for use 4.2.4.    Where specific to the use, the instructions for safe disposal of the product and its packaging See general directions for use 4.2.5.    Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage See general directions for use 5.    GENERAL DIRECTIONS FOR USE   ( 1 ) 5.1.   Instructions for use For professional use only. 5.2.   Risk mitigation measures Avoid contact with eyes. Keep out of reach of children. 5.3.    Particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment First-aid measures general: Move the affected person away from the contaminated area. Get medical advice/attention if you feel unwell. If possible, show this sheet. IF INHALED: Move to fresh air and keep at rest in a position comfortable for breathing. Call a POISON CENTRE or a doctor. IF ON SKIN: Immediately wash skin with plenty of water. Thereafter take off all contaminated clothing and wash it before reuse. Continue to wash the skin with water for 15 minutes. Call a POISON CENTRE or a doctor. IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing for at least 15 minutes. Call 112/ambulance for medical assistance. Information to Healthcare personnel/doctor:   The eyes should also be rinsed repeatedly on the way to the doctor if eye exposure to alkaline chemicals (pH > 11), amines and acids like acetic acid, formic acid or propionic acid.   IF SWALLOWED: Immediately rinse mouth. Give something to drink, if exposed person is able to swallow. Do NOT induce vomiting. Call 112/ambulance for medical assistance.   Accidental release measures: Stop leak if safe to do so. Remove ignition sources. Use special care to avoid static electric charges. No open flames. No smoking. Prevent entry to sewers and public waters. Wipe up with absorbent material (for example cloth). Soak up spills with inert solids, such as clay or diatomaceous earth as soon as possible. Take up mechanically (sweeping, shovelling). Dispose of in accordance with relevant local regulations. 5.4.    Instructions for safe disposal of the product and its packaging Disposal must be done according to official regulations. Do not empty into drains. Do not dispose of with domestic waste. Dispose of contents/container to an authorised waste collection point. Empty the packaging completely prior to disposal. When totally empty, containers are recyclable like any other packing. 5.5.    Conditions of storage and shelf-life of the product under normal conditions of storage Shelf-life: 24 months Store in dry, cool, well-ventilated area. Keep container tightly closed. Keep out of direct sunlight. Recommended storage temperature: 0-30°C Do not store at temperatures below 0°C Do not store near food, drink and animal feedingstuff. Keep away from combustible material. 6.    OTHER INFORMATION ( 1 )   Instructions for use, risk mitigation measures and other directions for use under this section are valid for any authorised uses.

Other acts of the same type
Commission Implementing Regulation (EU) 2025/1897 of 12 September 2025 amending for the 349th time Council Regulation (EC) No 881/2002 imposing certain specific restrictive measures directed against certain persons and entities associated with the ISIL (Da’esh) and Al-Qaida organisationsCommission Implementing Regulation (EU) 2025/1906 of 12 September 2025 granting a Union authorisation for the biocidal product family GA 24-50 BPF in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2025/2179 of 12 September 2025 laying down implementing technical standards for the application of Regulation (EU) 2023/2631 of the European Parliament and of the Council with regard to the standard forms, templates, and procedures for the provision of the information for an application for registration as an external reviewer for European Green BondsCommission Delegated Regulation (EU) 2025/2180 of 12 September 2025 supplementing Regulation (EU) 2023/2631 of the European Parliament and of the Council with regard to regulatory technical standards specifying the conditions for the registration of external reviewers, the criteria for assessing the sound and prudent management of external reviewers, the appropriateness of the knowledge, experience and training of the external reviewers’ employees, and the conditions under which external reviewers can outsource their assessment activitiesCommission Implementing Regulation (EU) 2025/1803 of 11 September 2025 cancelling the Union authorisation for the single biocidal product Nordkalk QL 90 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council and repealing Commission Implementing Regulation (EU) 2024/1672Commission Implementing Regulation (EU) 2025/1846 of 11 September 2025 cancelling the Union authorisation for the single biocidal product Nordkalk QL 0-0,1 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council and repealing Commission Implementing Regulation (EU) 2024/1478Commission Implementing Regulation (EU) 2025/1882 of 11 September 2025 amending Annex I to Implementing Regulation (EU) 2023/594 laying down special disease control measures for African swine feverCommission Implementing Regulation (EU) 2025/1885 of 11 September 2025 granting a Union authorisation for the biocidal product family BPF Propan-2-ol Dr Deppe in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2025/1905 of 11 September 2025 granting a Union authorisation for the biocidal product family desmanol pure in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2025/1800 of 10 September 2025 amending Implementing Regulation (EU) 2023/753 as regards administrative changes to the Union authorisation for the biocidal product family C(M)IT/MIT formulationsCommission Implementing Regulation (EU) 2025/1867 of 10 September 2025 granting a Union authorisation for the single biocidal product Sterillium liquid in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCommission Delegated Regulation (EU) 2025/2184 of 10 September 2025 amending Delegated Regulations (EU) 2016/232 and (EU) 2017/891 as regards certain rules on producer organisations, notification obligations of producer prices and implementation of certain import mechanisms in the fruit and vegetables sector

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next